Abstract
The herpes virus family is ubiquitous in the population and causes a wide spectrum of ocular disease. The name herpes originates from the Greek word herpein, meaning to creep reflecting both creeping/spreading nature of skin lesions associated with many members of the herpes virus family and the ability of the virus to remain latent prior to causing recurring infections in their host. The use of this term dates back to ancient Greece, confirming the longevity and hardiness of this viral family. The herpesviridae family each share the common structure of double-stranded DNA (dsDNA) enclosed by a viral envelope. All are nuclear replicating, with viral DNA being transcribed to mRNA within an infected cell. Once a person is infected, generally by close physical contact, the virus remains viable for life and can reactivate at any time following the primary infection. There are eight known herpes virus types that affect humans: herpes simplex virus 1 (HSV-1), herpes simplex virus 1 (HSV-2), varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein--barr virus (EBV), human herpes virus 6, and human herpes virus 8. The first four are most likely to cause ocular disease. Ocular disease caused by the herpesviridae family can occur either in the anterior or posterior segment and includes some of the most devastating forms of retinitis. The pattern and presentation of disease is related to the immune status of the patient with the severely immunocompromised at greatest risk for developing a severe necrotizing retinitis. Treatment is based on the location of disease with anterior segment disease managed with a combination of systemic antivirals and topical agents. Posterior segment disease always requires systemic antiviral therapy and local therapy with intravitreal injections of antiviral medications in selected patients. Atypical cases of herpes virus associated disease often lead to delay in diagnosis. However, the increasing availability of PCR analysis of intraocular fluids has increased our diagnostic efficiency. To benefit from this improved technology and advances in treatment, it is critical to maintain a high level of clinical suspicion for this virus in all cases of ocular inflammation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thygeson P, Hogan MJ, Kimura SJ. Observations on uveitis associated with viral disease. Trans Am Ophthalmol Soc. 1957;55:333.
O’Connor GF. Recurrent herpes simplex uveitis in humans. Surv Ophthalmol. 1976;21:165–70.
Jap A, Chee S. Viral Anterior Uveitis. Curr Opin Ophthal. 2011;22(6):483–8.
Sungur GK, Hazirolan D, Yalvac IS, et al. Incidence and prognosis of ocular hypertension secondary to viral uveitis. Int Ophthalmol. 2010;30:191–4.
Tugal-Tutkun I, Otük-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int Ophthalmol. 2010;30:559–65.
Barron BA, Gee L, Hauck WW, et al. Herpetic eye disease study: a controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1871–82.
Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Barron BA, Kaufman HE, Sugar J, Hyndiuk RA, Laibson PR. Herpetic eye disease study: a controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1883–96.
Van Rooig J, Rigneveld W, Remeijer L, et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology. 2003;110:1916–9.
Rapauno C, Azari A. What’s Ahead in Cornea. Medscape. December 9th 2013.
Virus VZ. Herpes zoster overview: natural history and incidence. J Am Osteopath Assoc. 2009;109(2):S2–6.
Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.
Yamamoto S, Pavan-Langston D, Tada R, et al. Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol. 1995;119:796–8.
Anwar Z, Galor A, Albini TA, Miller D, Perez V, Davis JL. The diagnostic utility of anterior chamber paracentesis with polymerase chain reaction in anterioruveitis. Am J Ophthalmol. 2013;155(5):781–6.
Urayama A, Yamada N, Sasaki T, et al. Unilateral acute uveitis with retinal periarteritis and detachment. Jpn J Clin Ophthalmol. 1971;25:607.
Culbertson WW, Blumenkranz MS, Haines H, Gass DM, Mitchell KB, Norton EW. The acute retinal necrosis syndrome. Part 2: histopathology and etiology. Ophthalmology. 1982;89(12):1317–25.
Young NJ, Bird AC. Bilateral acute retinal necrosis. Br J Ophthalmol. 1978;62(9):581–90.
Sternberg P, Knox DL, Finkelstein D, Green WR, Murphy RP, Patz A. Acute retinal necrosis syndrome. Retina. 1982;2(3):145–51.
Fisher JP, Lewis ML, Blumenkranz M, Culbertson WW, Flynn HW Jr, Clarkson JG, Gass JD, Norton EW. The acute retinal necrosis syndrome. Part 1: Clinical manifestations. Ophthalmology. 1982;89(12):1309–16.
Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive committee of the American Uveitis society. Am J Ophthalmol. 1994;117(5):663–7.
Sugita S, Shimizu N, Watanabe K, Mizukami M, Morio T, Sugamoto Y, Mochizuki M. Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol. 2008;92(7):928–32.
Sugita S, Ogawa M, Shimizu N, Morio T, Ohguro N, Nakai K, Maruyama K, Nagata K, Takeda A, Usui Y, Sonoda KH, Takeuchi M, Mochizuki M. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology. 2013;120(9):1761–8.
Tran TH, Rozenberg F, Cassoux N, Rao NA, LeHoang P. Bodaghi B Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis. Br J Ophthalmol. 2003;87(1):79–83.
Wensing B, de Groot-Mijnes JD, Rothova A. Necrotizing and nonnecrotizing variants of herpetic uveitis with posterior segment involvement. Arch Ophthalmol. 2011;129(4):403–8.
Tibbetts MD, Shah CP, Young LH, Duker JS, Maguire JI, Morley MG. Treatment of acute retinal necrosis. Ophthalmology. 2010;117(4):818–24.
Palay DA, Sternberg P, Davis J, Lewis H, Holland GN, Mieler WF, Jabs DA, Drews C. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol. 1991;112(3):250–5.
Aizman A, Johnson MW, Elner SG. Treatment of acute retinal necrosis syndrome with oral antiviral medications. Ophthalmology. 2007;114:307–12.
Aslanides IM, Giavedoni LR, Altomare F, Detorakis ET, Kymionis GD, Pallikaris IG. Oral valacyclovir in the treatment of acute retinal necrosis syndrome. Retina. 2002;22:352–4.
Emerson GG, Smith JR, Wilson DJ, Rosenbaum JT, Flaxel CJ. Primary treatment of acute retinal necrosis with oral antiviral therapy. Ophthalmology. 2006;113:2259–61.
Figueroa MS, Garabito I, Gutierrez C, Fortun J. Famciclovir for the treatment of acute retinal necrosis (ARN) syndrome. Am J Ophthalmol. 1997;123:255–7.
Garner HR, Latkany P. Oral drugs for viral retinitis Ophthalmology. 2007;114:2368.
Huynh TH, Johnson MW, Comer GM, Fish DN. Vitreous penetration of orally administered valacyclovir. Am J Ophthalmol. 2008;145:682–8.
Luu KK, Scott IU, Chaudhry NA, Verm A, Davis JL. Intravitreal antiviral injections as adjunctive therapy in the management of immunocompetent patients with necrotizing herpetic retinopathy. Am J Ophthalmol. 2000;129(6):811–3.
Flaxel CJ, Yeh S, Lauer AK. Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013;111:133–44.
Wong R, Pavesio CE, Laidlaw DA, Williamson TH, Graham EM, Stanford MR. Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome. Ophthalmology. 2010;117(3):556–60.
Lau CH, Missotten T, Salzmann J. Lightman S. Acute retinal necrosis features, management, and outcomes Ophthalmology. 2007;114:756–62.
Forster D, Dugel P, Frangieh G, Liggett P, Rao N. Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1990;110(4):341–8.
Gore DM, Gore SK, Visser L. Progressive outer retinal necrosis: outcomes in the intravitreal era. Arch ophthalmol. 2012;130(6):700–6.
Scott I, Luu K, Davis J. Intravitreal antivirals in the management of patients with acquired immunodeficiency syndrome with progressive outer retinal necrosis. Arch Ophthalmol. 2002;120(9):1219–22.
Lewis JM, Nagae Y, Tano Y. Progressive outer retinal necrosis after bone marrow transplantation. Am J Ophthalmol. 1996;122(6):892–5.
Kalpoe JS, van Dehn CE, Bollemeijer JG, Vaessen N, Claas EC, Barge RM, Willemze R, Kroes AC, Beersma MF. Varicella zoster virus (VZV)- related progressive outer retinal necrosis (PORN) after allogenic stem cell transplantation. Bone Marrow Transplant. 2005;36(5):467–9.
Khot A, Dignan F, Taylor S, Potter M, Cubitt D, Treleaven JG. Another case of PORN (bilateral progressive outer retinal necrosis) after allogeneic stem celltransplantation. Bone Marrow Transplant. 2006;37(1):113–4.
Engstrom RE Jr, Holland GN, Margolis TP, Muccioli C, Lindley JI, Belfort R Jr, Holland SP, Johnston WH, Wolitz RA, Kreiger AE. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS, Ophthalmology. 1994;101(9):1488–502.
Moorthy RS, Weinberg DV, Teich SA, Berger BB, Minturn JT, Kumar S, Rao NA, Fowell SM, Loose IA, Jampol LM. Management of varicella zoster virus retinitis in AIDS. Br J Ophthalmol. 1997;81(3):189–94.
Ormerod LD, Larkin JA, Margo CA, Pavan PR, Menosky MM, Haight DO, Nadler JP, Yangco BG, Friedman SM, Schwartz R, Sinnott JT. Rapidly progressive herpetic retinal necrosis: a blinding disease characteristic of advanced AIDS. Clin Infect Dis. 1998;26(1):34–45.
Gore DM, Gore SK, Visser L. Progressive outer retinal necrosis: outcomes in the intravitreal era. Archives of ophthalmology. 2012;130(6):700–6.
Blair MP, Goldstein DA, Shapiro MJ. Optical coherence tomography of progressive outer retinal necrosis. Retina. 2007;27(9):1313–4.
Galindez OA, Sabates NR, Whitacre MM, Sabates FN. Rapidly progressive outer retinal necrosis caused by varicella zoster virus in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1996;22(1):149–51.
Kuppermann BD, Quiceno JI, Wiley C, Hesselink J, Hamilton R, Keefe K, Garcia R, Freeman WR. Clinical and histopathologic study of varicella zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1994;118(5):589–600.
Morley MG, Duker JS, Zacks C. Successful treatment of rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1994;117(2):264–5.
Peck R, Gimple SK, Gregory DW, Youree B. Progressive outer retinal necrosis in a 73-year-old man: treatment with valganciclovir. AIDS. 2003;17(7):1110–1.
Yin P, Kurup S, Fischer S, Rhee H, Bymes G, Levy-Clarke G, Buggage R, Nussenblatt R, Mican J, Wright M. Progressive outer retinal necrosis in the era of highly active antiretroviral therapy: Successful management with intravitreal injections and monitoring with quantitative PCR. J Clin Virol. 2007;38(3):254–9 Epub 2007 Feb 5.
Roig-Melo E, Macky T, Heredia-Elizondo M, Alfaro D. Progressive outer retinal necrosis syndrome: successful treatment with a new combination of antiviral drugs. Eur J Ophthalmol. 2001;11(2):200–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Flynn, T., Ackert, J. (2017). Herpes Simplex and Herpes Zoster. In: Papaliodis, G. (eds) Uveitis. Springer, Cham. https://doi.org/10.1007/978-3-319-09126-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-09126-6_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09125-9
Online ISBN: 978-3-319-09126-6
eBook Packages: MedicineMedicine (R0)